{"id":350,"date":"2022-01-26T08:58:19","date_gmt":"2022-01-26T08:58:19","guid":{"rendered":"https:\/\/dolia.co.uk\/dsru\/?page_id=350"},"modified":"2023-03-23T11:22:56","modified_gmt":"2023-03-23T11:22:56","slug":"dsru-news","status":"publish","type":"page","link":"https:\/\/www.dsru.org\/information-news\/dsru-news\/","title":{"rendered":"DSRU News"},"content":{"rendered":"\n
\n
\n\n<\/div>\n\n
\n
\n\t\t\t\t
\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"DSRU\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Shaping Vaccine Safety Evidence Across Europe<\/h3>\n\t\t\t\t\t

DSRU colleagues have contributed to a major VAC4EU study examining thrombosis with thrombocytopaenia syndrome (TTS) \u2014 a rare blood clotting condition \u2014 following the Oxford-AstraZeneca...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"DSRU\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

DSRU attends ISoP Mid-Year Meeting<\/h3>\n\t\t\t\t\t

Some of the DSRU\u2019s pharmacovigilance experts attended the mid year meeting of the International Society of Pharmacovigilance (ISoP) in Hatfield, UK, this week. DSRU Director,...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

DSRU\/ PIPA Webinar: Additional Risk Minimisation Measures<\/h3>\n\t\t\t\t\t

The DSRU physicians, Dr Miranda Davies and Dr Sandeep Dhanda, were delighted to present a webinar to members of the Pharmaceutical Information & Pharmacovigilance Association...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Causality Assessment Tools: Scoping Review Published<\/h3>\n\t\t\t\t\t

The International Working Group (IWG) on New Developments in Pharmacovigilance has conducted a scoping review of Causality Assessment Tools (CATs) developed or updated between 2008...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

DSRU Co-Hosts VAC4EU General Assembly in Southampton<\/h3>\n\t\t\t\t\t

The Drug Safety Research Unit (DSRU) is proud to co-host the 13th General Assembly Meeting of the Vaccine monitoring Collaboration for Europe (VAC4EU) at the...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"DSRU\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Challenges in monitoring safety of GLP-1 agonists<\/h3>\n\t\t\t\t\t

Our recent editorial published in Drug Safety Journal describes the Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) that are currently available for use in the UK,...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Latest perspectives on PV data access and integration<\/h3>\n\t\t\t\t\t

The latest research from the DSRU\u2019s International Working Group on New Developments in Pharmacovigilance has been published by Drug Safety. This work draws on the...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Post-authorisation safety study (PASS) completed for Glycopyrronium Bromide<\/h3>\n\t\t\t\t\t

The DSRU conducted a PASS in the UK on Glycopyrronium Bromide 1mg\/5ml oral solution, a medicine which is prescribed to treat severe drooling in children...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Fruitful DSRU-MHRA work session<\/h3>\n\t\t\t\t\t

This week teams from DSRU and MHRA held a very successful work session to explore emerging challenges and opportunities in the UK pharmacovigilance landscape. We...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

The DSRU is now a member of the SIGMA Consortium<\/h3>\n\t\t\t\t\t

We are delighted to announce that the DSRU is the newest member of the SIGMA Consortium. The consortium was established by ENCePP (the European Network...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Study report published: myo- and pericarditis following Pfizer Covid vaccination<\/h3>\n\t\t\t\t\t

The final report has been published for one of our collaborative studies into aspects of safety of the Pfizer-BioNTech Covid vaccine.  The study aimed to...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

DSRU team’s busy conference season\u00a0<\/h3>\n\t\t\t\t\t

Members of the DSRU team have been busy over the past few months participating in a number of key events in drug and vaccine safety...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Efficient PASS based on bespoke data collection in secondary care<\/h3>\n\t\t\t\t\t

One of our key capabilities is to design and conduct PASS studies using bespoke data collection in primary, secondary or specialist care. While we use...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

VAC4EU is 5 years old!<\/h3>\n\t\t\t\t\t

The DSRU team attended 5th anniversary celebrations of the Vaccine monitoring Collaboration for Europe (VAC4EU) in Brussels in November, joining with colleagues from across Europe...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Linda H\u00e4rmark attends ISoP Annual Meeting in Cairo<\/h3>\n\t\t\t\t\t

Linda H\u00e4rmark attended the Annual Meeting of the International Society of Pharmacovigilance (ISoP) in Cairo and gave a presentation on \"What matters? Different perspectives and...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

DSRU attends World Vaccine Congress Europe<\/h3>\n\t\t\t\t\t

We attended the World Vaccine Congress in Amsterdam in October, as part of a large delegation from Vaccine Monitoring Collaboration for Europe (VAC4EU). The DSRU\u2019s...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

DSRU attends World Drug Safety Congress Europe<\/h3>\n\t\t\t\t\t

The DSRU team had a very busy few days at the World Drug Safety Congress (WDSC) Europe in Amsterdam recently.  We received a lot of...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

The safety of paracetamol during pregnancy<\/h3>\n\t\t\t\t\t

The DSRU confirms that current evidence does not support a causal link between paracetamol use in pregnancy and autism. A large and rigorous Swedish study...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

ISPE 2025: Spotlights on Real-World Evidence<\/h3>\n\t\t\t\t\t

The DSRU team attended the 41st International Society for Pharmacoepidemiology (ISPE) Annual Conference in Washington DC, where researchers, regulators, and industry leaders explored the evolving...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Looking forward to the ISPE Annual Meeting in Washington DC!<\/h3>\n\t\t\t\t\t

The DSRU team will be attending the 41st Annual Meeting of the International Society for Pharmacoepidemiology (ISPE) in Washington on 23rd-26th August. We will present...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

DSRU joins Life Sciences Institute launch event at University of Portsmouth<\/h3>\n\t\t\t\t\t

A team from DSRU was pleased to participate in the launch of the Institute of Life Sciences and Healthcare (ILSH) at the University of Portsmouth...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Risk of Guillain-Barr\u00e9 syndrome after COVID-19 disease or vaccine<\/h3>\n\t\t\t\t\t

A large-scale international study involving researchers from the DSRU has highlighted the relationship between SARS-CoV-2 infection, certain COVID-19 vaccines, and Guillain-Barr\u00e9 syndrome (GBS). The research,...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Major real world safety study on Covid vaccine published<\/h3>\n\t\t\t\t\t

The DSRU has recently published the findings of its major post-authorisation safety study (PASS) on the AstraZeneca Covid vaccine in BMJ Open. This large scale...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Linda H\u00e4rmark starts as new DSRU Director<\/h3>\n\t\t\t\t\t

Dr Linda H\u00e4rmark has taken over the role of Director from Professor Saad Shakir, who has stepped down after 26 years at the DSRU. The...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

VAC4EU Consortium\u2019s General Assembly Meeting<\/h3>\n\t\t\t\t\t

Members of the DSRU\u2019s Epidemiology team attended VAC4EU\u2019s General Assembly Meeting in Valencia recently, accompanied by Linda H\u00e4rmark, our new Director. The first day focused...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Linda H\u00e4rmark announced as new Director of the DSRU<\/h3>\n\t\t\t\t\t

We are delighted to announce that Linda H\u00e4rmark will be our new Director from 22 April 2025. Dr H\u00e4rmark succeeds Professor Saad Shakir who is...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

DSRU paper on lecanemab pharmacovigilance perspective<\/h3>\n\t\t\t\t\t

Our paper on lecanemab, a new anti-amyloid drug to treat Alzheimer\u2019s Disease, emphasises the need for robust pharmacovigilance monitoring in order to determine its safety...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

CPRD studies: How we use UK electronic health record (EHR) data<\/h3>\n\t\t\t\t\t

Conducting real-world post-authorisation studies on data from the Clinical Practice Research Datalink (CPRD) is one of the DSRU\u2019s core activities. Recognition of the importance of...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

DSRU delivers Real World Evidence training to FPM physicians<\/h3>\n\t\t\t\t\t

The DSRU team delivered a very successful one day hybrid training event on \u201cUnderstanding and Interpreting Studies Using Real-World Data\u201d, at the Faculty of Pharmaceutical...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

12th Signal Detection conference: DSRU\u2019s flagship event!<\/h3>\n\t\t\t\t\t

Our eagerly anticipated conference on Signal Detection and Signal Management will take place in London on 15-17th October. Don\u2019t miss this opportunity to hear from...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

14 August 2024<\/p>\n \t

Looking forward to ICPE in Berlin!<\/h3>\n\t\t\t\t\t

The DSRU team will be attending the 40th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) in Berlin on 24-28th August. The wide variety...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"Saad\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Professor Saad Shakir, Director of the Drug Safety Research Unit, to step down next year<\/h3>\n\t\t\t\t\t

Professor Saad Shakir, Director of the Drug Safety Research Unit (DSRU) based in Southampton, has today announced his intention to step down as Director with...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Our new course on Developing Gravitas in Pharmacovigilance<\/h3>\n\t\t\t\t\t

We are looking forward to our new masterclass on Developing Gravitas in Pharmacovigilance on 30th\u00a0July. Gravitas is a crucial skill for business success, enabling leaders...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

5 July 2024<\/p>\n \t

Saad Shakir celebrates 25 years as DSRU Director<\/h3>\n\t\t\t\t\t

In this month\u2019s PharmaTimes, Saad Shakir gives an interview in which he reflects on his 25 years at the Drug Safety Research Unit. He focuses...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

19 June 2024<\/p>\n \t

Discussing Evidence Supporting Regulatory Decisions at DIA Global!<\/h3>\n\t\t\t\t\t

At the DIA 2024 Global Annual Meeting in San Diego, Saad Shakir (DSRU Director), chaired a very successful session on \u201cEvidence Generation to Support Regulatory...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

3 June 2024<\/p>\n \t

New self-development courses<\/h3>\n\t\t\t\t\t

We are delighted to announce an exciting development in DSRU Education & Training with the addition of a panel courses on self-development, management and leadership....<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Meet the new Head of Education and Training at the DSRU<\/h3>\n\t\t\t\t\t

For more than 20 years, Dr Alison Evans has been conducting complex and vigorous studies into the safety of vaccines and drugs used in healthcare...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

16 May 2024<\/p>\n \t

DSRU urges uptake of vaccination amid steep rise in UK whooping cough cases<\/h3>\n\t\t\t\t\t

The UK Health Security Agency (UKHSA) has published data showing a continued increase in monthly cases of whooping cough in the UK. The UKHSA reminded...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Post-authorisation study on AstraZeneca Covid vaccine completed!<\/h3>\n\t\t\t\t\t

The COVID-19 vaccines were developed and tested rapidly, meaning that it was especially important to monitor their safety and effectiveness in the post-authorisation setting. The...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

DSRU Systematic Reviews for Safety: latest publication<\/h3>\n\t\t\t\t\t

The DSRU conducts systematic literature reviews to support evidence-based decisions in drug safety. We recently published a systematic review on the safety of a non-steroidal...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

International Working Group publishes first paper<\/h3>\n\t\t\t\t\t

The International Working Group (IWG) on New Developments in Pharmacovigilance has published its first paper. The paper details the IWG\u2019s work in two areas in...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"child\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

DSRU joins experts in recommending MMR vaccination<\/h3>\n\t\t\t\t\t

The UK Health Security Agency (UKHSA) has urged parents to ensure their children are fully vaccinated with the Measles, Mumps, Rubella (MMR) vaccine, in order...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

European Network Studies Q&A<\/h3>\n\t\t\t\t\t

We asked Dr Miranda Davies, the DSRU\u2019s Chief Medical Officer, to explain the key characteristics of European Network Studies: Q. What are the DSRU\u2019s European...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

International Working Group makes progress with causality and data sources<\/h3>\n\t\t\t\t\t

The International Working Group (IWG) on New Developments in Pharmacovigilance has been working hard throughout 2023. The IWG brings together around 70 experts from across...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

What we do and reasons to approach the DSRU for your next observational study<\/h3>\n\t\t\t\t\t

The DSRU is a service provider and independent research organisation that conducts observational studies for both large and small pharma companies. These companies appreciate that...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"ICPE\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Looking forward to ICPE in Halifax!<\/h3>\n\t\t\t\t\t

The DSRU team will be attending the 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) in Halifax, Canada on 23-27th August. The wide...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Pan-European study of Covid vaccine safety published<\/h3>\n\t\t\t\t\t

The DSRU conducted the UK arm of this study which focused on the safety of all Covid-19 vaccines and was led by Lareb, the Netherlands...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

DSRU attends DIA Europe conference<\/h3>\n\t\t\t\t\t

The DSRU team was delighted to attend the DIA Europe conference in Basel in March 2023 and to promote our capabilities as the UK\u2019s leading...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

How we’re leading UK pharmacovigilance<\/h3>\n\t\t\t\t\t

Here at the Drug Safety Research Unit, we are proud to be the UK's leading pharmacovigilance and pharmacoepidemiology unit.  We have conducted hundreds of post-authorisation...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

International group redoubles efforts to improve detection of drug side effects<\/h3>\n\t\t\t\t\t

The International Working Group (IWG) on New Developments in Pharmacovigilance has resumed its work in earnest, following an extended break due to the pandemic. Members...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

30 September 2022<\/p>\n \t

Just published: our paper on cases of thrombosis with concurrent thrombocytopenia following AstraZeneca Covid-19 vaccine.<\/h3>\n\t\t\t\t\t

In March 2021, rare signals of unusual clotting with concurrent low platelets began to emerge in people who had received at least one dose of...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

<\/p>\n \t

Good to be back at ICPE!<\/h3>\n\t\t\t\t\t

The DSRU had a great conference at ICPE (International Conference on Pharmacoepidemiology & Therapeutic Risk Management) in Copenhagen last week. The in-person annual conference of...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

20 May 2022<\/p>\n \t

Our biennial Signal Detection conference is back!<\/h3>\n\t\t\t\t\t

After an extended break due to the pandemic, we are delighted that our iconic 11th Biennial Conference on Signal Detection and Signal Management in Pharmacovigilance...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

18 May 2022<\/p>\n \t

Risk minimisation at the DSRU<\/h3>\n\t\t\t\t\t

\u201cThe right medicine, at the right dose, at the right time, to the right patient\u201d (GVP, Module XVI) Risk minimisation measures are actions taken to...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

9 May 2022<\/p>\n \t

DSRU hosts ISoP Mid-Year Symposium<\/h3>\n\t\t\t\t\t

Beyond Spontaneous Reporting: integrating data from multiple sources to ensure medicines safety The Drug Safety Research Unit (DSRU) hosts an important international meeting for the...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

22 March 2022<\/p>\n \t

Institute of Pharmacovigilance Sciences launched to improve global drug safety research methods<\/h3>\n\t\t\t\t\t

The  Drug Safety Research Unit has today launched a new global Institute of Pharmacovigilance Sciences. A team of DSRU physicians, epidemiologists and biomedical scientists will...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

17 March 2022<\/p>\n \t

DSRU launches Institute of Pharmacovigilance Sciences with free webinar<\/h3>\n\t\t\t\t\t

The DSRU Institute of Pharmacovigilance Sciences has been established to build on the DSRU\u2019s  methodological research in pharmacovigilance and pharmacoepidemiology. The launch of the Institute...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

8 March 2022<\/p>\n \t

DSRU expands research team and 80% are women, nearly double the UK average in science roles<\/h3>\n\t\t\t\t\t

Ahead of International Women\u2019s Day on Tuesday 8 March, the UK\u2019s independent Drug Safety Research Unit (DSRU) has announced it\u2019s doubled the size of its...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

3 March 2022<\/p>\n \t

Myocarditis and pericarditis in immunocompromised patients following COVID-19 mRNA vaccination<\/h3>\n\t\t\t\t\t

Summary: Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination Two years after the start...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

3 December 2021<\/p>\n \t

The DSRU and the Future of UK Pharmacoepidemiology & Pharmacovigilance<\/h3>\n\t\t\t\t\t

The DSRU has expanded enormously in the last few years.  As the UK\u2019s premier unit for pharmacoepidemiology and pharmacovigilance, we have a full understanding of the...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

17 September 2021<\/p>\n \t

Pericarditis and myocarditis following mRNA vaccination: our review<\/h3>\n\t\t\t\t\t

The UK\u2019s independent Drug Safety Research Unit (DSRU) has concluded that heart inflammation after mRNA COVID-19 vaccines is very rare and mild in the vast...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

25 August 2021<\/p>\n \t

Podcast: how we have been monitoring the safety of Covid vaccines<\/h3>\n\t\t\t\t\t

Listen to Saad Shakir on the MedTalk Podcast: Understanding Covid-19 vaccines with the DSRU. The DSRU is monitoring the safety of most of the UK\u2019s...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

2 August 2021<\/p>\n \t

Vaccination provides weaker COVID-19 protection for immunocompromised patients<\/h3>\n\t\t\t\t\t

The DSRU Global Pharmacovigilance Observatory recently completed a systematic review of multiple studies comparing the immune response to COVID-19 vaccines in immunocompromised patients with that...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

16 July 2021<\/p>\n \t

DSRU Observational Studies on the COVID19 vaccines<\/h3>\n\t\t\t\t\t

Recruitment of participants is almost complete for our post-authorisation study to monitor the safety of the AstraZeneca COVID-19 vaccine. The study uses active surveillance methodology,...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

6 April 2021<\/p>\n \t

Pharmacovigilance Evidence Review: Rare blood clots with AstraZeneca COVID-19 vaccine in women under 55<\/h3>\n\t\t\t\t\t

Rare blood clots with AstraZeneca COVID-19 vaccine in women under 55 The DSRU has evaluated all publicly available data on blood clotting incidents after immunisation...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

12 March 2021<\/p>\n \t

Pharmacovigilance Evidence Review: Thrombosis following vaccination with COVID-19 AstraZeneca Vaccine<\/h3>\n\t\t\t\t\t

Professor Saad Shakir and Samantha Lane 12 March 2021 We agree with MHRA and EMA that people should continue to be vaccinated with the Oxford\/AstraZeneca...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

23 November 2020<\/p>\n \t

Investigating Serious Adverse Events in COVID-19 Vaccine Trials<\/h3>\n\t\t\t\t\t

Despite the urgent need for a COVID-19 vaccine, it is of critical importance that the process of safety evaluation is not compromised in any way....<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

13 November 2020<\/p>\n \t

Drugs repurposed for COVID-19 still need rigorous testing<\/h3>\n\t\t\t\t\t

Existing drugs repurposed to treat COVID-19 still need rigorous testing for safety and effectiveness and the DSRU is urging institutions across the globe to work...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

6 November 2020<\/p>\n \t

Rivaroxaban hospital PASS (ROSE study) papers published!<\/h3>\n\t\t\t\t\t

Two papers on the findings of our Rivaroxaban Observational Safety Evaluation (ROSE) study have just been published. ROSE is is a prime example of our...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

22 October 2020<\/p>\n \t

Paper published: Can post-marketing studies provide a safety net for COVID-19 vaccines in the UK?<\/h3>\n\t\t\t\t\t

Our new paper published in BMJ Evidence Based Medicine explains that, given the speed with which potential new COVID-19 vaccines are being developed, it is...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

14 October 2020<\/p>\n \t

DSRU comment on pausing of J&J COVID-19 vaccine trial<\/h3>\n\t\t\t\t\t

Director, Professor Saad Shakir,  said: \u201cSerious adverse events are expected in a clinical trial that includes 60,000 vaccinees. While the independent Data Safety Monitoring Board...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

5 October 2020<\/p>\n \t

Remdesivir for COVID-19 patients is \u2018favourable\u2019 says first systematic benefit-risk study<\/h3>\n\t\t\t\t\t

Remdesivir for COVID-19 patients is \u2018favourable\u2019 says first systematic benefit-risk study The first comprehensive evaluation of all possible benefits and risks of remdesivir The benefits...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

18 September 2020<\/p>\n \t

DSRU presents first ISoP journal club!<\/h3>\n\t\t\t\t\t

DSRU Senior Clinical Research Fellow, Dr Miranda Davies, and Director, Professor Saad Shakir, presented the first ever online journal club for the International Society of...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

27 August 2020<\/p>\n \t

Insufficient evidence for use of convalescent plasma in COVID-19 patients<\/h3>\n\t\t\t\t\t

Convalescent plasma (CP) treatment is one treatment option currently being investigated in COVID-19. Our review of evidence for a living systematic benefit-risk assessment of the...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

11 August 2020<\/p>\n \t

The One Million Study to monitor safety and effectiveness of COVID-19 vaccines<\/h3>\n\t\t\t\t\t

Our UK COVID-19 Vaccine Consortium has announced plans for the One Million Post-Authorisation Study to monitor the safety and effectiveness of the COVID-19 vaccine in...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

29 June 2020<\/p>\n \t

Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment<\/h3>\n\t\t\t\t\t

Our dynamic systematic benefit-risk analysis of antiviral drug combination lopinavir-ritonavir for COVID-19 patients has just been published. Our research team found there was no clear...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

22 June 2020<\/p>\n \t

New consortium to monitor safety and effectiveness of COVID-19 vaccines<\/h3>\n\t\t\t\t\t

A new consortium to monitor the safety and effectiveness of COVID-19 vaccines has been formed by the Drug Safety Research Unit and MEMO Research, University...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

29 May 2020<\/p>\n \t

First systematic benefit-risk assessment of Remdesivir published<\/h3>\n\t\t\t\t\t

Remdesivir for COVID-19 patients is \u2018favourable\u2019 says first systematic benefit-risk study We have just published the first ever systematic benefit-risk analysis of antiviral drug remdesivir...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

27 May 2020<\/p>\n \t

Hospital PASS studies: conducting real-world observational studies in secondary care<\/h3>\n\t\t\t\t\t

Our article in the Spring edition of Pharmafile explains our unique SCEM method for conducting PASS studies in hospitals and specialist care in the context...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

14 May 2020<\/p>\n \t

The need for active surveillance of the safety and effectiveness of COVID-19 vaccines<\/h3>\n\t\t\t\t\t

(First published as a BMJ Rapid Response on 12th May 2020) A key component of efforts to control COVID-19 will be an effective vaccine. There...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

30 April 2020<\/p>\n \t

COVID-19: DSRU’s latest research and capabilities update<\/h3>\n\t\t\t\t\t

The DSRU team is heavily engaged in conducting studies related to the COVID-19 pandemic. Dozens of clinical trials are underway around the world, many on...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

28 April 2020<\/p>\n \t

Business as usual at the DSRU<\/h3>\n\t\t\t\t\t

The DSRU team is used to working remotely while maintaining high standards and completing studies on time. We have the connectivity to enable us to...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

30 March 2020<\/p>\n \t

Article: The need for evolution in pharmacovigilance<\/h3>\n\t\t\t\t\t

Pharmafocus published an interview with our Director, Saad Shakir, in its March issue, focusing on the need for pharmacovigilance to evolve in order to handle...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

26 February 2020<\/p>\n \t

Systematic Benefit-Risk Assessment published<\/h3>\n\t\t\t\t\t

Benefit-risk assessment is used to weigh up the benefits of a specific treatment with the risks of that treatment. The DSRU team has just published...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

26 February 2020<\/p>\n \t

Developing Gravitas: A masterclass in maximising your leadership potential<\/h3>\n\t\t\t\t\t

Improving your presence and impact in your organisation We are delighted to be working in collaboration with The Gravitas Programme to bring you a new...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

7 February 2020<\/p>\n \t

Milestone 20 years for DSRU pharmacovigilance training<\/h3>\n\t\t\t\t\t

DSRU Education & Training is celebrating two decades of training health and pharmaceutical professionals, many of whom have gone on to senior UK pharmacovigilance roles....<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

20 January 2020<\/p>\n \t

New course for 2020 – Vigilance of Medical Devices<\/h3>\n\t\t\t\t\t

Addressing the uncertainty around implementation of the Medical Devices Regulation (MDR) The new European regulations on medical devices entered into force in 2017 and must...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

3 January 2020<\/p>\n \t

Improvements needed in recording brand and batch numbers for biological medicines to ensure patient safety<\/h3>\n\t\t\t\t\t

Health professionals need to improve how they record brand and batch numbers for biologic medicines to ensure patients stay safe, according to a new study...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

5 November 2019<\/p>\n \t

GPs urged to help improve patient safety<\/h3>\n\t\t\t\t\t

The DSRU had coverage in the BMJ last week following the issue of the press release below. The article is available to BMJ subscribers here....<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

25 October 2019<\/p>\n \t

DSRU team at RCGP Annual Conference!<\/h3>\n\t\t\t\t\t

The DSRU team is delighted to be at the Annual Conference of the Royal College of General Practitioners (RCGP) in Liverpool. Our medics are on...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

14 October 2019<\/p>\n \t

Improving detection of adverse drug reactions<\/h3>\n\t\t\t\t\t

DSRU Director, Professor Saad Shakir, attended a three day meeting in Erice in Sicily on \u201cImproving the Detection Analysis and Reporting Harms in Medicines\u201d. The...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

8 October 2019<\/p>\n \t

Expanding the reach of Pharmacovigilance education with the Royal Pharmaceutical Society<\/h3>\n\t\t\t\t\t

The DSRU is delighted to be collaborating with the Royal Pharmaceutical Society to deliver two new training days. The courses are designed to introduce the...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

24 September 2019<\/p>\n \t

DSRU Consultancy: World class science at a not for profit price!<\/h3>\n\t\t\t\t\t

DSRU Consultancy has a small flexible team of epidemiologists, clinicians and pharmacists. Watch this short video to find out how DSRU Consultancy provides advice in pharmacoepidemiology, pharmacovigilance, risk minimisation and...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

13 September 2019<\/p>\n \t

Success of Big Data for Pharmacovigilance Conference!<\/h3>\n\t\t\t\t\t

The DSRU\u2019s Second Conference on Big Data for Pharmacovigilance has been a great success. Delegates from regulatory bodies, the pharmaceutical industry and academia have heard...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

27 August 2019<\/p>\n \t

The DSRU is at ICPE in Philadelphia!<\/h3>\n\t\t\t\t\t

The DSRU team is attending the International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) in Philadelphia. Come and meet our team at booth 204,...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

2 August 2019<\/p>\n \t

Big Data for Pharmacovigilance: looking forward to our 2nd conference!<\/h3>\n\t\t\t\t\t

Our second conference on Big Data for Pharmacovigilance takes place in September in London. We have an impressive line-up of speakers who will examine the...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

26 July 2019<\/p>\n \t

The importance of recording brand and batch numbers of prescribed biologic medicines<\/h3>\n\t\t\t\t\t

In 2017-18, the NHS saved over \u00a3200 million by using more biosimilar medicines1. In 2018, NHS England announced plans to increase the uptake of biosimilars...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

23 July 2019<\/p>\n \t

Congratulations to our 2019 Graduates!<\/h3>\n\t\t\t\t\t

Congratulations to our students who graduated from Masters in Pharmacovigilance earlier this month. Students graduating either completed their Postgraduate Certificate, Diploma or Masters in Pharmacovigilance,...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

8 July 2019<\/p>\n \t

IWG on Signal Detection & Management holds launch call<\/h3>\n\t\t\t\t\t

The launch teleconference for the International Working Group (IWG) on Signal Detection and Management in Pharmacovigilance took place last week. The key points raised included:...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\t\t\t

\t\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\"\"\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

28 June 2019<\/p>\n \t

IWG on Signal Detection & Management gets underway!<\/h3>\n\t\t\t\t\t

The International Working Group (IWG) on Signal Detection and Management in Pharmacovigilance is taking shape.  The IWG now includes members from nearly 20 pharmaceutical companies,...<\/p>\n\t\t\t\t\t

Continue reading<\/a><\/p>\n <\/div>\n\t\t <\/div>\n\t\n\t\t\t\t\n\t\n\n\t\t\n\t<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":20,"featured_media":0,"parent":22,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-standard.php","meta":{"_acf_changed":false,"footnotes":""},"coauthors":[52],"class_list":["post-350","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nLatest News & Company Updates | DSRU<\/title>\n<meta name=\"description\" content=\"Read the latest news and updates from the Drug Safety Research Unit (DSRU) to find out what we are working on.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dsru.org\/information-news\/dsru-news\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Latest News & Company Updates | DSRU\" \/>\n<meta property=\"og:description\" content=\"Read the latest news and updates from the Drug Safety Research Unit (DSRU) to find out what we are working on.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dsru.org\/information-news\/dsru-news\/\" \/>\n<meta property=\"og:site_name\" content=\"DSRU\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DrugSafetyResearchUnit\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-23T11:22:56+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@DSRUDrugSafety\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n\t<meta name=\"twitter:label2\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data2\" content=\"Emily Axten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.dsru.org\\\/information-news\\\/dsru-news\\\/\",\"url\":\"https:\\\/\\\/www.dsru.org\\\/information-news\\\/dsru-news\\\/\",\"name\":\"Latest News & Company Updates | DSRU\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dsru.org\\\/#website\"},\"datePublished\":\"2022-01-26T08:58:19+00:00\",\"dateModified\":\"2023-03-23T11:22:56+00:00\",\"description\":\"Read the latest news and updates from the Drug Safety Research Unit (DSRU) to find out what we are working on.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.dsru.org\\\/information-news\\\/dsru-news\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.dsru.org\\\/information-news\\\/dsru-news\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.dsru.org\\\/information-news\\\/dsru-news\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.dsru.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Information & News\",\"item\":\"https:\\\/\\\/www.dsru.org\\\/information-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"DSRU News\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.dsru.org\\\/#website\",\"url\":\"https:\\\/\\\/www.dsru.org\\\/\",\"name\":\"DSRU\",\"description\":\"The UK\u2019s leading pharmacovigilance and pharmacoepidemiology unit.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.dsru.org\\\/#organization\"},\"alternateName\":\"Drug Safety Research Unit\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.dsru.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.dsru.org\\\/#organization\",\"name\":\"DSRU\",\"alternateName\":\"Drug Safety Research Unit\",\"url\":\"https:\\\/\\\/www.dsru.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.dsru.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.dsru.org\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/cropped-DSRU_Branding.png\",\"contentUrl\":\"https:\\\/\\\/www.dsru.org\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/cropped-DSRU_Branding.png\",\"width\":250,\"height\":115,\"caption\":\"DSRU\"},\"image\":{\"@id\":\"https:\\\/\\\/www.dsru.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/DrugSafetyResearchUnit\",\"https:\\\/\\\/x.com\\\/DSRUDrugSafety\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/drug-safety-research-unit\\\/\",\"https:\\\/\\\/www.instagram.com\\\/drugsafetyresearchunit\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Latest News & Company Updates | DSRU","description":"Read the latest news and updates from the Drug Safety Research Unit (DSRU) to find out what we are working on.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dsru.org\/information-news\/dsru-news\/","og_locale":"en_GB","og_type":"article","og_title":"Latest News & Company Updates | DSRU","og_description":"Read the latest news and updates from the Drug Safety Research Unit (DSRU) to find out what we are working on.","og_url":"https:\/\/www.dsru.org\/information-news\/dsru-news\/","og_site_name":"DSRU","article_publisher":"https:\/\/www.facebook.com\/DrugSafetyResearchUnit","article_modified_time":"2023-03-23T11:22:56+00:00","twitter_card":"summary_large_image","twitter_site":"@DSRUDrugSafety","twitter_misc":{"Estimated reading time":"1 minute","Written by":"Emily Axten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.dsru.org\/information-news\/dsru-news\/","url":"https:\/\/www.dsru.org\/information-news\/dsru-news\/","name":"Latest News & Company Updates | DSRU","isPartOf":{"@id":"https:\/\/www.dsru.org\/#website"},"datePublished":"2022-01-26T08:58:19+00:00","dateModified":"2023-03-23T11:22:56+00:00","description":"Read the latest news and updates from the Drug Safety Research Unit (DSRU) to find out what we are working on.","breadcrumb":{"@id":"https:\/\/www.dsru.org\/information-news\/dsru-news\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dsru.org\/information-news\/dsru-news\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.dsru.org\/information-news\/dsru-news\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.dsru.org\/"},{"@type":"ListItem","position":2,"name":"Information & News","item":"https:\/\/www.dsru.org\/information-news\/"},{"@type":"ListItem","position":3,"name":"DSRU News"}]},{"@type":"WebSite","@id":"https:\/\/www.dsru.org\/#website","url":"https:\/\/www.dsru.org\/","name":"DSRU","description":"The UK\u2019s leading pharmacovigilance and pharmacoepidemiology unit.","publisher":{"@id":"https:\/\/www.dsru.org\/#organization"},"alternateName":"Drug Safety Research Unit","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dsru.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.dsru.org\/#organization","name":"DSRU","alternateName":"Drug Safety Research Unit","url":"https:\/\/www.dsru.org\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.dsru.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.dsru.org\/wp-content\/uploads\/2022\/01\/cropped-DSRU_Branding.png","contentUrl":"https:\/\/www.dsru.org\/wp-content\/uploads\/2022\/01\/cropped-DSRU_Branding.png","width":250,"height":115,"caption":"DSRU"},"image":{"@id":"https:\/\/www.dsru.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/DrugSafetyResearchUnit","https:\/\/x.com\/DSRUDrugSafety","https:\/\/www.linkedin.com\/company\/drug-safety-research-unit\/","https:\/\/www.instagram.com\/drugsafetyresearchunit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/pages\/350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/comments?post=350"}],"version-history":[{"count":9,"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/pages\/350\/revisions"}],"predecessor-version":[{"id":3876,"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/pages\/350\/revisions\/3876"}],"up":[{"embeddable":true,"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/pages\/22"}],"wp:attachment":[{"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/media?parent=350"}],"wp:term":[{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/coauthors?post=350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}